Co-founders of NPLIN, Anne Spasojevic & Dania Mellah are developing a device that uses a laser beam to enhance and induce nucleation in pharmaceutical solutions, for which interest has been validated by a market study from Paris-Saclay University.
The application areas primarily concern the pharmaceutical and chemical sectors.
What is the current status of their project?
- Invention disclosure
- Patent filed in Sept 2024
- Development of a robotic platform V1 for selling molecule-specific studies
- Development of a robotic platform V2 for sale and installation at industrial sites
- Startup creation
Technological maturity : TRL 3
